Innoviva (INVA) Assets (2010 - 2026)

Innoviva (INVA) posted Assets of $1.8 billion for Q1 2026, up 12.32% on a QoQ basis from $1.6 billion in Q4 2025, and up 46.41% year-over-year from $1.3 billion in Q1 2025.

Innoviva (INVA) Assets (2010 - 2026) Analysis & Trends

Innoviva's Assets history runs 17 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

  • Quarterly Assets rose 46.41% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 46.41% YoY) and the FY2025 annual result came in at $1.6 billion, up 25.68% from the prior year.
  • Assets was $1.8 billion for Q1 2026 at Innoviva, up from $1.6 billion in the prior quarter.
  • Across five years, Assets topped out at $1.8 billion in Q1 2026 and bottomed at $1.1 billion in Q1 2022.
  • A 5-year average of $1.3 billion and a median of $1.2 billion in 2023 frame the typical range for Assets.
  • Annual changes were most pronounced in 2022 — Assets soared 49.65% — and 2023, when it decreased 10.51%.
  • Innoviva's Assets stood at $1.2 billion in 2022, then gained by 0.98% to $1.2 billion in 2023, then gained by 4.63% to $1.3 billion in 2024, then increased by 25.68% to $1.6 billion in 2025, then advanced by 12.32% to $1.8 billion in 2026.
  • Business Quant data shows INVA's Assets at $1.8 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.4 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 311.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 78.88 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.55 Bn
4 NuCana 279.75 Bn 279.75 Bn - 39.68 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.48 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.87 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 811.27 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 10.03 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.25 Bn
10 Innoviva 1.57 Bn 969.11 Mn 75.83 Mn 1.84 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.84 Bn
Dec 31, 2025 1.64 Bn
Sep 30, 2025 1.43 Bn
Jun 30, 2025 1.33 Bn
Mar 31, 2025 1.25 Bn
Dec 31, 2024 1.30 Bn
Sep 30, 2024 1.23 Bn
Jun 30, 2024 1.22 Bn
Mar 31, 2024 1.27 Bn
Dec 31, 2023 1.24 Bn
Sep 30, 2023 1.19 Bn
Jun 30, 2023 1.12 Bn
Mar 31, 2023 1.13 Bn
Dec 31, 2022 1.23 Bn
Sep 30, 2022 1.33 Bn
Jun 30, 2022 1.14 Bn
Mar 31, 2022 1.11 Bn
Dec 31, 2021 926.40 Mn
Sep 30, 2021 887.24 Mn
Jun 30, 2021 789.15 Mn